Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.WT | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Pfizer or Roche as jv partners for the NMIBC

<< Previous

Bullboard Posts

Next >>

Comment by ScienceFirston Jan 25, 2023 8:48am

222 Views

Post# 35244642

RE:RE:RE:Pfizer or Roche as jv partners for the NMIBC

Patience69 ... Negociations take time. You have to reach to all big pharmas, then wait for their reply, analyze them, then back and forth, narrow down to few, then legal, etc ... I've shown some examples that took 1-1.5y so TLT has a good timeline. In the meantime, our valuation will keep evolving with data. ASCO is the first of many official exposures to come, now that we have interim data. We're on the map now and for good reason and with data to back it. Fun time ahead.

<< Previous

Bullboard Posts

Next >>

Victoria Gold stock falls 82% after Yukon landslide halts production